CIK 0001691082 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LB PHARMACEUTICALS INC
Sign in to watch- Ticker
- LBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-450-6581
- Business address
- 575 MADISON AVENUE, NEW YORK, NY, 10022
- Former names
- LB PHARMACEUTICALS INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-10 | PRENSKY ZACHARY Director | Grant or award · Stock Option (Right to Buy) | +53,787 | 53,787 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Grant or award · Stock Option (Right to Buy) | +22,449 | 22,449 | ||
| 2025-09-10 | Nussbaum Ran Director | Grant or award · Stock Option (Right to Buy) | +22,449 | 22,449 | ||
| 2025-09-10 | Garland J. Scott Director | Returned to the company · Employee Stock Option (Right to Buy) | −17,929 | 0 | ||
| 2025-09-10 | Garland J. Scott Director | Grant or award · Employee Stock Option (Right to Buy) | +17,929 | 17,929 | ||
| 2025-09-10 | Garland J. Scott Director | Returned to the company · Employee Stock Option (Right to Buy) | −3,585 | 0 | ||
| 2025-09-10 | Garland J. Scott Director | Grant or award · Employee Stock Option (Right to Buy) | +3,585 | 3,585 | ||
| 2025-09-10 | Garland J. Scott Director | Grant or award · Employee Stock Option (Right to Buy) | +22,449 | 22,449 | ||
| 2025-09-10 | Silva Richard Anthony SVP, Technical Operations | Returned to the company · Employee Stock Option (Right to Buy) | −8,964 | 0 | ||
| 2025-09-10 | Silva Richard Anthony SVP, Technical Operations | Grant or award · Employee Stock Option (Right to Buy) | +8,964 | 8,964 | ||
| 2025-09-10 | Silva Richard Anthony SVP, Technical Operations | Grant or award · Employee Stock Option (Right to Buy) | +80,899 | 80,899 | ||
| 2025-09-10 | Eramo Anna Chief Medical Officer | Returned to the company · Employee Stock Option (Right to Buy) | −26,893 | 0 | ||
| 2025-09-10 | Eramo Anna Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +26,893 | 26,893 | ||
| 2025-09-10 | Eramo Anna Chief Medical Officer | Returned to the company · Employee Stock Option (Right to Buy) | −6,275 | 0 | ||
| 2025-09-10 | Eramo Anna Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +6,275 | 6,275 | ||
| 2025-09-10 | Eramo Anna Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +155,812 | 155,812 | ||
| 2025-09-10 | Soffer Gad Chief Business Officer | Returned to the company · Employee Stock Option (Right to Buy) | −26,893 | 0 | ||
| 2025-09-10 | Soffer Gad Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +26,893 | 26,893 | ||
| 2025-09-10 | Soffer Gad Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +229,860 | 229,860 | ||
| 2025-09-10 | Turner Heather D Chief Executive Officer | Returned to the company · Employee Stock Option (Right to Buy) | −175,706 | 0 |
Page 4 of 5 · 84 trades